Alpha 2.0
Login Register
» Authors » S DellArte

S DellArte

Explore the profile of S DellArte including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 13
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Top 10 Co-Authors
R Messina
R A Mangiafico
L S Malatino
T Attina
M Santonocito
R S Spada
F Sarnataro
M Di Battista
G Biasco
L Giuliano
Published In
Minerva Cardioangiol
Int Angiol
Panminerva Med
Angiology
Int J Clin Pharmacol Ther
Affiliations
Soon will be listed here.
Recent Articles
1.
[Treatment of colorectal cancer liver metastases]
Derenzini E, Di Battista M, Di Marco M, DellArte S, Astorino M, Bertolini S, et al.
Minerva Med . 2006 Mar; 97(1):107-19. PMID: 16565703
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected by CRC develop liver metastases. Surgery remains the only potentially curative strategy and indications...
2.
Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication
Mangiafico R, Messina R, Attina T, DellArte S, Giuliano L, Malatino L
Angiology . 2000 Jun; 51(6):441-9. PMID: 10870853
Intermittent claudication impairs functional status and quality of life in many patients by limiting walking capacity. The aim of this study was to evaluate the effects of a 4-week treatment...
3.
Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb
Mangiafico R, Malatino L, Spada R, Santonocito M, Messina R, DellArte S, et al.
Int Angiol . 2000 Jun; 19(1):14-7. PMID: 10853680
Background: Endothelin-1 (ET-1) is an endothelial vasoconstrictor mitogenic peptide which is thought to be a marker of endothelial damage and a potential participant in the pathophysiological processes of the development...
4.
[Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2]
Mangiafico R, Malatino L, Attina T, DellArte S, Messina R
Minerva Cardioangiol . 2000 Feb; 47(12):652-3. PMID: 10670246
No abstract available.
5.
Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication
Mangiafico R, Malatino L, Santonocito M, Messina R, Attina T, DellArte S, et al.
Int J Clin Pharmacol Ther . 1999 Aug; 37(7):347-51. PMID: 10442509
Objective: Endothelin-1 (ET-1) is a vasoconstrictor mitogenic peptide whose plasma concentrations are increased in patients with peripheral arterial occlusive disease (PAOD). The aim of this study was to investigate whether...
6.
Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages
Mangiafico R, Malatino L, Santonocito M, Sarnataro F, DellArte S, Messina R, et al.
Panminerva Med . 1999 May; 41(1):22-6. PMID: 10230252
Unlabelled: Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogenic peptide produced and secreted by endothelial cells, which can play a potential role in the development of atherosclerosis and in the...
7.
[Hypertensive encephalopathy associated with malignant and resistant hypertension]
Mangiafico R, Spada R, Messina R, Attina T, Santonocito M, DellArte S
Minerva Cardioangiol . 1999 Feb; 46(9):347-8. PMID: 10021875
No abstract available.